Edition:
United Kingdom

Taiko Pharmaceutical Co Ltd (4574.T)

4574.T on Tokyo Stock Exchange

1,843JPY
16 Jan 2019
Change (% chg)

¥-14 (-0.75%)
Prev Close
¥1,857
Open
¥1,854
Day's High
¥1,871
Day's Low
¥1,838
Volume
11,800
Avg. Vol
26,313
52-wk High
¥2,598
52-wk Low
¥1,611

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -- March 16 Jan 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 0 0 0 0
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 3.00 3.00 3.00 3.00

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 1 2,649.00 2,649.00 2,649.00 --
Year Ending Mar-19 1 9,250.00 9,250.00 9,250.00 9,350.00
Year Ending Mar-20 1 9,800.00 9,800.00 9,800.00 9,730.00
Earnings (per share)
Year Ending Mar-19 1 74.70 74.70 74.70 74.35
Year Ending Mar-20 1 83.80 83.80 83.80 81.40

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 2,250.00 2,560.11 310.11 13.78
Quarter Ending Jun-18 1,260.00 1,265.00 5.00 0.40
Quarter Ending Mar-18 2,390.00 2,745.73 355.73 14.88
Quarter Ending Dec-17 3,396.00 3,078.82 317.18 9.34
Quarter Ending Sep-17 2,303.00 2,237.04 65.96 2.86

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 2,649.00 2,649.00 2,649.00 2,715.00 --
Year Ending Mar-19 9,250.00 9,250.00 9,250.00 9,200.00 9,350.00
Year Ending Mar-20 9,800.00 9,800.00 9,800.00 9,800.00 9,730.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-19 0 0 0 0
Year Ending Mar-19 0 0 0 0
Year Ending Mar-20 0 0 0 0
Earnings